With the U.S. increasingly dependent on foreign manufacturers for prescription and generic drugs, the Food and Drug Administration's problem-plagued efforts to inspect overseas plants are under growing scrutiny.
Tag: Pharmaceutical Industry and Drugs
Fifteen years ago, the federal government said “no” to piracetam. The agency hasn’t changed its position. But piracetam is widely available—and hugely popular—as a supplement promoted as boosting cognitive ability. Unintimidated by FDA warning letters, sellers are advertising this forbidden ingredient in online bazaars.
In an age of distortion, propaganda and fake news, medical literature might seem to be a safe space for honest scientific inquiry, with no room for bias or spin. It isn't so. Court proceedings, investigations and whistleblower accounts have revealed a long history of drug companies manipulating the literature to promote their drugs or disparage rival products--with the aim of getting doctors to prescribe more of their meds
A decade after General Motors teetered on bankruptcy, workers say they want some payback for their sacrifices.
Fresh off a spat with car makers, the Trump administration seems to be walking into another fight with a big industry over whether deregulation is going too far. The EPA has laid out a plan to roll back regulation of methane gas, saying it will save the oil and gas industry money.
Convenience, selection and quick delivery have made Amazon a trusted brand. But a team of Wall Street Journal reporters found thousands of products for sale on Amazon that wouldn’t be permitted on the shelves of big box stores because they had been deemed unsafe or were outright banned by federal regulators.
New members of EPA science advisory panels, including some with industry ties, were not not properly screened for ethical conflicts, according to the Government Accountability Office.
The beverage industry trumpets its efforts at sustainability. Coca Cola, for example, has set a goal of making a full half of its packaging from recycled material by 2030. Yet, the industry repeatedly has blocked a key tool in increasing recycling rates: the bottle bill.
Lawyers presented a federal judge in Ohio with a proposal that would allow every town, city or county in the country to receive a payment from the companies that have made and sold prescription opioids. Local governments opting in to the settlement would get money to help address the public health crisis stemming from opioid abuse.
Uber and Lyft have been talking a lot about safety lately, with a focus on making sure customers feel safe with their drivers. But what about the vehicles themselves?